2015-08-012024-05-14https://scholars.lib.ntu.edu.tw/handle/123456789/655412摘要：台灣大學為台灣學界的龍頭，各學院的研究能量豐沛，台灣大學附設醫院 (台大醫院）有優異醫療團隊與研究環境，臨床試驗與研究之經驗豐富成 果卓越。而台灣大學產學合作中心對於新產品的商業化有豐富經驗，結合 這些能量，繼續將此「生醫與醫材轉譯加值人才培訓計晝」推向第三年， 藉由關鍵經費與商業化專家的協助，計晝篩選或延續共約10至15件與新 醫療器材及新藥有關的計晝，讓台大醫院的醫師與其他學院的研發人才組 成團隊，並加入校外精英團隊，加以培訓與協助，希望讓這些團隊的研究 在生技產業的商業化進程能往前走關鍵的一步，並連接產、官、學三方面 創造三赢，以期將來能有高影響高產值的生技產品出現，提升台灣在全球 醫療產業的產值。<br> Abstract: National Taiwan University (NTU) is the leading academic institute in Taiwan with diverse research programs in life science, engineering, and clinical medicine. The NTU Hospital has excellent medical team and research environment, and is experienced in clinical trials and biomedical research. Moreover, the Industry-Academia Cooperation Center of NTU has many successful examples in new product development and subsequent commercialization. Combining all the above resources, the investigators hereby submit the 3rd year’s “Anchor University proposal，，to the Ministry of Science and Technology. The proposed program will facilitate the development and commercialization of new drugs and medical devices in Taiwan. Through the support of gap fund and experienced commercialization experts, we plan to select ten to fifteen Research and Development teams, including at least one non-NTU team. These teams will be led by both a medical doctor and an expert from a college or specialty outside of the NTU College of Medicine. The program office will facilitate training of team members to translate their research towards commercial products. Intensive development tasks will be carried out, with milestone-based funding. Combining resources and expertise from the academia, government, and industry, high-impact biotechnological products will be developed in the near future.醫療器材藥醫療臨床試驗產學合作Medical deviceDrugMedicineClinical TrialIndustry-Academia Cooperation Center